Abstract
Background
Objective
Methods
Results
Conclusions
Key words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsReferences
Aranesp (darbepoetin alfa) [prescribing information]. Thousand Oaks, Calif: Amgen Inc; 2012.
Epogen (epoetin alfa) [prescribing information]. Thousand Oaks, Calif: Amgen Inc; 2012.
National Kidney Foundation. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-KDOQI). http://www.kidney.org/professionals/kdoqi/. Accessed May 24, 2013.
- KDIGO clinical practice guideline for anemia in chronic kidney disease.Kidney Int Suppl. 2012; 2 (http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO-Anemia%20GL.pdf. Accessed September 14, 2012): 279-335
Department of Health and Human Services: Centers for Medicare & Medicaid Services. End Stage Renal Disease Prospective Payment System: Final Rule and Proposed Rule, CMS-1418-F, RIN 0938-AP57, 42 CFR Parts 410, 413 and 414. August 12, 2010.
Department of Health and Human Services: Centers for Medicare & Medicaid Services. End Stage Renal Disease Quality Incentive Program: Final Rule, CMS-3206-F, RIN 0938-AP91, 42 CFR Part 413. January 5, 2011.
US Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012.
Arbor Research Collaborative for Health. DOPPS practice monitor. http://www.dopps.org/DPM/DPMSlideBrowser.aspx. Accessed May 24, 2013.
Collins AJ. ESRD Payment policy changes: the new “bundled” dialysis Prospective Payment System (PPS) in the United States. Paper presented at: NKF Spring Clinical Meeting; May 9–13, 2012; Washington DC. http://www.usrds.org/2012/pres/USDialysisBundle_impact_NKFCM2012.pdf. Accessed August 7, 2012.
University of Michigan Kidney Epidemiology and Cost Center. 2012 Dialysis facility report. http://www.dialysisreports.org/pdf/esrd/public/SampleReport.pdf. Accessed November 27, 2012.
- The 2009 proposed rule for prospective ESRD payment: perspectives from a for-profit small dialysis organization.Am J Kidney Dis. 2010; 55: 231-233
- The initiation of dialysis in undocumented aliens: the impact on a public hospital system.Am J Kidney Dis. 2004; 43: 424-432
- The impact of inadequate pre-dialysis care and undocumented aliens on an urban hospital based (HB) dialysis center.J Am Soc Nephrol. 2008; 19: 503a
- Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation.Blood. 2010; 115: 4284-4292
- Sensitization.Clin Transpl. 1988; : 365-373
- Blood transfusions in kidney transplant candidates are common and associated with adverse outcomes.Clin Transplant. 2011; 25: 653-659
- The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation.Ann Transplant. 2003; 8: 17-24
- Collaborative Transplant Study: non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.Lancet. 2005; 365: 1570-1576
- Predicting kidney graft failure by HLA antibodies: a prospective trial.Am J Transplant. 2004; 4: 438-443
- Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial.Transplant. 2005; 80: 1194-1197
- An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival.BMC Nephrol. 2013; 14: 217
- Impact of cadaveric renal transplantation on survival in patients listed for transplantation.J Am Soc Nephrol. 2005; 16: 1859-1865
- Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.JAMA. 1993; 270: 1339-1343
Centers for Medicare & Medicaid Services (US). Decision memo for erythropoiesis stimulating agents (ESAs) for treatment of anemia in adults with CKD including patients on dialysis and patients not on dialysis (CAG-00413N). http://www.cms.gov/medicare-coverage-database/shared/handlers/highwire.ashx?url=http://www.cms.gov/medicare-coverage-database/details/[email protected]@@NCAId$$$245***fromdb$$$true&session=pmxvqg55lvnia1qjijs5dlyu&kq=1821578349. Accessed August 29, 2012.
- Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.Cochrane Database Syst Rev. 2003; (CD003967)
Hackbarth GM. Medicare Payment Advisory Commission (MedPAC) comment letter on QIP proposed rule, file code CMS-1352-P. http://www.medpac.gov/documents/08312012_ESRD_comment.pdf. Accessed September 4, 2012.
Pederson S, Valez RL. American Association of Kidney Patients/Renal Physicians Association: letter to Congress requesting reversals of ESA label change/drop of the QIP lower Hb target. http://www.renalmd.org/uploadedFiles/Content/Legislation,_Regulation_and_Compliance/Congressional_Communications/AAKP-RPA%20Letter%20on%20ESAs%209-19.pdf. Accessed September 25, 2012.
- Variability of ferritin measurements in chronic kidney disease: implications for iron management.Kidney Int. 2009; 75: 104-110
- Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients.Kidney Int. 2004; 65: 1091-1098
- Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.J Am Soc Nephrol. 2013; 24: 1150-1158
- Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.Clin J Am Soc Nephrol. 2010; 5: 576-581
- A low serum iron level is a predictor of poor outcome in hemodialysis patients.Am J Kidney Dis. 2004; 43: 671-684
- TSAT is a better predictor than ferritin of hemoglobin response to epoetin alfa in US dialysis patients.Hemodial Int. 2014; 18: 38-46
- Review: use of electronic medical records for health outcomes research: a literature review.Med Care Res Rev. 2009; 66: 611-638
- Release 0.0: clinical information technology in the real world.Health Aff (Millwood). 1998; 17: 23-38
Renal Network of the Upper Midwest, Inc. Elab Project. National 2010 and Trends Elab Report. http://www.esrdnet11.org/Elab/elab_national_2010_and_trends_report.pdf. Accessed September 10, 2012.
